BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9174000)

  • 1. Identification of a unique apolipoprotein E allele in Microcebus murinus; ApoE brain distribution and co-localization with beta-amyloid and tau proteins.
    Calenda A; Jallageas V; Silhol S; Bellis M; Bons N
    Neurobiol Dis; 1995 Jun; 2(3):169-76. PubMed ID: 9174000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Amyloid protein precursor in Microcebus murinus: genotyping and brain localization.
    Silhol S; Calenda A; Jallageas V; Mestre-Frances N; Bellis M; Bons N
    Neurobiol Dis; 1996; 3(3):169-82. PubMed ID: 8980017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
    Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
    Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression of beta-amyloid precursor protein (betaAPP) and apolipoprotein E in cell culture: analysis of betaAPP processing.
    Biere AL; Ostaszewski B; Zhao H; Gillespie S; Younkin SG; Selkoe DJ
    Neurobiol Dis; 1995 Jun; 2(3):177-87. PubMed ID: 9174001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain.
    Higgins LS; Murphy GM; Forno LS; Catalano R; Cordell B
    Am J Pathol; 1996 Aug; 149(2):585-96. PubMed ID: 8701997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Similarities between cerebral amyloid plaques in aged lemurian and in human with Alzheimer's disease].
    Bons N; Mestre N
    C R Seances Soc Biol Fil; 1993; 187(4):516-25. PubMed ID: 8019922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
    Williams S; Chalmers K; Wilcock GK; Love S
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):414-21. PubMed ID: 16008825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
    Aleshkov S; Abraham CR; Zannis VI
    Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.
    Ikonomovic MD; Uryu K; Abrahamson EE; Ciallella JR; Trojanowski JQ; Lee VM; Clark RS; Marion DW; Wisniewski SR; DeKosky ST
    Exp Neurol; 2004 Nov; 190(1):192-203. PubMed ID: 15473992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical characterization of Tau proteins during cerebral aging of the lemurian primate Microcebus murinus.
    Bons N; Jallageas V; Silhol S; Mestre-Frances N; Petter A; Delacourte A
    C R Acad Sci III; 1995 Jan; 318(1):77-83. PubMed ID: 7757807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes.
    Utter S; Tamboli IY; Walter J; Upadhaya AR; Birkenmeier G; Pietrzik CU; Ghebremedhin E; Thal DR
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):842-56. PubMed ID: 18716559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model.
    Holtzman DM; Fagan AM; Mackey B; Tenkova T; Sartorius L; Paul SM; Bales K; Ashe KH; Irizarry MC; Hyman BT
    Ann Neurol; 2000 Jun; 47(6):739-47. PubMed ID: 10852539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of differential immune factors in temporal cortex and cerebellum: the role of alpha-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease.
    Styren SD; Kamboh MI; DeKosky ST
    J Comp Neurol; 1998 Jul; 396(4):511-20. PubMed ID: 9651008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
    Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning of the presenilin 2 cDNA and its distribution in brain of the primate, Microcebus murinus: coexpression with betaAPP and Tau proteins.
    Calenda A; Mestre-Francés N; Czech C; Pradier L; Petter A; Perret M; Bons N; Bellis M
    Neurobiol Dis; 1998 Nov; 5(5):323-33. PubMed ID: 10069575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocyte lipoproteins, effects of apoE on neuronal function, and role of apoE in amyloid-beta deposition in vivo.
    Fagan AM; Holtzman DM
    Microsc Res Tech; 2000 Aug; 50(4):297-304. PubMed ID: 10936884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease.
    Pritchard A; Harris J; Pritchard CW; St Clair D; Lemmon H; Lambert JC; Chartier-Harlin MC; Hayes A; Thaker U; Iwatsubo T; Mann DM; Lendon C
    Neurosci Lett; 2005 Jul; 382(3):221-6. PubMed ID: 15925094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.